Dr. Dominick DePhilippis discusses Contingency Management for stimulant use disorders, emphasizing its use of incentives to reinforce abstinence behaviors. The episode explores the effectiveness of Contingency Management, challenges in implementation, and the role of smart gift cards in sustaining recovery. Also, it touches on emerging drug threats and resources for learning about CM in addiction treatment.

Clinicians who have lived with mental illness share how it impaired them - and strengthenedthem - on the job.CME: Take the CME Post-Test for this EpisodePublished On: 05/27/2024Duration: 21 minutes, 50 secondChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psychiatrist Chris Aiken, MD, and PMHNP Kellie Newsome discuss the interplay between genetics and environmental factors in depression, focusing on the serotonin transporter gene. They explore the impact of serotonin genes on antidepressant response rates, ethnic variations, and traits like stress resilience. The podcast also highlights the correlation between genotype and sensory information processing in babies and the role of the CERT gene in treatment response for PTSD.

Clinicians who have lived with mental illness show us how to build a deeper empathy from our past wounds, starting with Carl Jung.CME: Take the CME Post-Test for this EpisodePublished On: 05/13/2024Duration: 11 minutes, 14 secondChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Clinicians who live with mental illness share the do’s and don’t’s of self-disclosureCME: Take the CME Post-Test for this EpisodePublished On: 05/06/2024Duration: 21 minutes, 46 secondChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

14 clinicians with mental illness share how they ask patients about mania, depression, psychosis, OCD, panic disorder, addiction, trauma, and suicide.CME: Take the CME Post-Test for this EpisodePublished On: 04/29/2024Duration: 20 minutes, 08 secondChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Exploring the different treatment options for managing children with ADHD, including medication and therapies. Discussing the challenges of navigating the process of selecting effective treatments. Delving into evidence-based approaches, lifestyle changes, and preparing young adults with ADHD for college. Highlighting the challenges of accessing mental health support for college students and managing medication shortages for ADHD treatment.

Dr. Brian Hurley discusses rising stimulant-related morbidity, safety disparities between prescription stimulants and illicit substances, challenges in treating stimulant use disorder, universal naloxone access for overdose prevention, and emphasizing recovery from stimulant use.

Edward Shorter, a historian in psychiatry, discusses the mistakes made in the field over time. Topics include historical evolution of psychiatry, challenges in diagnostics and treatment, evolution of psychiatric medications, role of randomized controlled trials, controversies in psychiatric classification, and the shift from psychopathological entities to neurotransmitter deficiencies in psychiatric illnesses.

Psychiatrist Chris Aiken, MD, and Psychiatric Nurse Practitioner Kellie Newsome discuss the generic form of Vilazodone, exploring its efficacy in managing depression and anxiety disorders, its impact on treating anxious depression, and its tolerability compared to SSRIs. They highlight the importance of understanding the drug's mechanism of action, onset of action, and remission rates from trials and studies.